2020-11-12T06:00:01+00:00

EU to buy 300 million doses of Pfizer-BioNTech Covid-19 vaccine

The European Union will sign a fourth contract with the US pharmaceutical giant Pfizer and their German lab partner BioNTech to procure up to 300 million doses of their Covid-19 vaccine, if proven to be safe and effective against the virus.

"As a company founded in the heart of Europe, we are looking forward to supplying millions of people upon regulatory approval," so BioNTech's CEO Ugur Sahin in a statement Wednesday. On Tuesday, Sahin said on a call with reporters that said BioNTech's goal is to ramp up production of their vaccine candidate in the hopes of manufacture up to 1.3 billion doses by the end of 2021.

Sources: Content Sources

Source: CNN

Image Source

unsplash.com / GR Stocks

Pentributor:

Ashley Winkler

@ash

Highly edible human, designer of all things digital, co-founder of Pendect, creative native, constant wa/onderer, morse code lady, full-time dog pillow.

Card reviewed by: @christoph

Categorization: Locations & Places

European Union

Organizations & Institutions

Pfizer

Cookies🍪

Our website uses scripts, such as cookies, to technically provide the site ("essential scripts") and third-party website tracking technologies to provide and continually improve our services and display advertisements based on the perceived interests of users. By clicking the "Accept All" button, the website visitor agrees to the activation of all scripts. Essential cookies are also executed without the consent. The consent can be revoked or changed at any time with effect for the future. By clicking the "Reject" button, only essential cookies are used. In our data protection policy, we provide detailed information about the type and scope of data processing.

Accept All Reject